Giuffre Randall Michael
SEC CIK 1759822 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Dir | 398.6K | $451.3K | — | 12 | 2022-01-03 | 2026-01-02 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | A - Grant | $8.42 | +6,175 | 398.6K | +2% | +$52.0K | |
| DM | 2025-02-18 | 2025-02-13 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | M - OptEx | $2.56 | +17.0K | 392.4K | +5% | +$43.6K |
| 2025-01-03 | 2025-01-02 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | A - Grant | $5.34 | +10.9K | 375.4K | +3% | +$58.0K | |
| 2024-01-02 | 2024-01-02 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | A - Grant | $2.80 | +19.2K | 364.6K | +6% | +$53.7K | |
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | G - Gift | $0.00 | -15.0K | 345.4K | -4% | $0 | |
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | P - Purchase | $3.91 | +65.0K | 360.4K | +22% | +$254.2K | |
| 2023-01-03 | 2023-01-03 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | A - Grant | $1.53 | +35.1K | 295.4K | +13% | +$53.7K | |
| M | 2022-12-12 | 2022-12-08+ | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | P - Purchase | $1.42 | +57.1K | 223.1K | +34% | +$81.0K |
| M | 2022-12-08 | 2022-12-06+ | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | P - Purchase | $1.40 | +24.9K | 180.6K | +16% | +$34.7K |
| 2022-12-05 | 2022-12-01 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | P - Purchase | $1.19 | +819 | 178.3K | +0.5% | +$974.61 | |
| M | 2022-12-01 | 2022-11-29+ | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | P - Purchase | $1.20 | +67.2K | 177.5K | +61% | +$80.5K |
| 2022-01-03 | 2022-01-03 | DMAC | DiaMedica Therapeutics Inc. | Giuffre Randall Michael | Dir | A - Grant | $3.58 | +15.0K | 110.2K | +16% | +$53.8K |
Purchase Sale Sale after option exercise All abbreviations